What do you want to see in OTE in 2009?

Article

Fill in OTE's online readership survey for the chance to win €500 Marriott hotel vouchers.

This month we are launching our readership survey, which gives you the chance to get involved.

For me, this survey is incredibly important; it gives me the chance to read your thoughts alongside those of your fellow subscribers. I place such a huge emphasis on the results of this survey. It tells me what we are doing right, what we can improve on, what you want to see more of and, ultimately, how we can serve you better. So I urge you take the time to complete this online form, which is available on our website ( http://www.oteurope.com/readers/).

If the opportunity of having direct input into OTE's editorial direction from 2009 onwards isn't enough of an incentive for you, then let me also tell you that all survey respondents will be entered into a prize draw to win €500 of Marriott Hotel vouchers. These can be used either for business or pleasure and will be redeemable in all Marriott Hotels, globally. The winner will be announced on our website ( http://www.oteurope.com/) in August as well as in the print edition of OTE in September.

Best of luck and thank you!

Fedra PavlouEditor

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.